AsiaTIDES 2011
March 2-4, 2011 Sheraton Miyako Hotel Tokyo, Japan

Get a comprehensive scientific update on:

• Delivery technologies including intracellular targeting, chemical modifications, oral, liposomal and nanoparticle delivery
• Understanding of microRNA from Santaris, miRagen and University of Tokyo
• Manufacturing and analytical development for peptides and oligos
• Regulatory considerations and guidance updates from Oligo Safety Working Group, ICHS6 and Regado
• Valuable data on preclinical data and therapeutic candidates from around the world
• Challenges and solutions for the delivery of siRNA and Peptide Therapeutics

Plus, In-depth Tutorials on:

• Bioanalytical Techniques for Oligonucleotides and Peptides
• Lessons Learned on the Way to an IND from Real Life Experience with Oligonucleotides and Peptides

Keynote Presentations

Design of Lipid Nanoparticle Systems for the Systemic Delivery of siRNA Pieter R. Cullis, Ph.D. Professor, Biochemistry and Molecular Biology University of British Columbia, Canada Supramolecular Structures from Block Copolymers for Nanocarriers in Oligonucleotide Delivery Kazunori Kataoka, Ph.D. Professor, Materials Engineering and Center for Disease Biology and Integrated Medicine University of Tokyo, Japan A Formulation/Device Combination for Peptide Drug Delivery Technosphere Technology Case Study Andrea Leone-Bay, Ph.D. Vice President, Pharmaceutical R&D, MannKind Corporation, USA

Transdermal Patch Delivery of Peptide Drugs Eric Tomlinson, Ph.D., D.Sc. President and Chief Executive Officer Altea Therapeutics Corporation, USA Clinical Breakthroughs in Transdermal Delivery of Peptides Daphna Heffetz, Ph.D. Chief Executive Officer and Director TransPharma Medical Ltd, Israel Stapled α-Helical Peptides: The Twists and Turns of Drug Discovery Tomi K. Sawyer, Ph.D. Senior Vice President and Chief Scientific Officer Aileron Therapeutics Inc., USA